Mental health digital therapeutic platform for psychedelic research released by Mind Cure

Mind Cure, a mental health company based in Canada, has recently developed a digital therapeutic platform which will bridge the gap between patients, researchers and doctors.

The new platform will work towards empowering patients so that they can be in charge of their healthcare journey. It also aims to create a database of healthcare practices and protocols for the community of psychedelic researchers.

The app, named iSTRYM, provides up-to-date and real-time data with regards to patient care, protocols and procedures. The platform is described as a central management system that can be used for various mental health treatment plans. This includes those relating to psychedelic therapeutic research.

The app uses data that has arisen separate from the psychedelic-assisted therapy sessions, like the weather, mood, heart rate or location. iSTRYM uses AI technology to produce insights found across various datasets to help clinicians move towards a well-decided diagnosis, including treatment plan and personal care of the patient.

Mind Cure aims to empower patients to take more initiative in their healthcare journey by converging these areas of data on the platform. The platform will also create a central database of clinical protocols and practices for the psychedelic research community.

Mind Cure’s mission is to recognise, develop and commercialise various products that will enhance wellness and mental health, increase productivity and ease suffering. The company’s main approach is via the ongoing research and utilization of psychedelic-assisted psychotherapy.

According to Mental Health America, the American’s mental health situation was worsening, even before the COVID-19 pandemic. Around 19% of adults in the USA experienced mental health issues between 2017 and 2018, this was an increase of 1.5 million people from the year before.

In the USA, the ever-increasing situation with the country’s mental health issues has directed some researchers to look into how effective psychedelic-assisted psychotherapy could be. Usually, this kind of treatment is professionally monitored and supervised as it uses drugs like MDMA, psilocybin, LSD, ketamine and ibogaine.

According to a report from The American Journal of Psychiatry, promising results have been found from the studies using psychedelics to treat psychiatric disorders. The review states that while there isn’t enough data to support approval from the FDA just yet, the existing data will support the ongoing research of psychedelics for routine clinical use.

When Oregon was the first state to legalise the use of psilocybin for mental health treatments in 2020, the use of psychedelic-assisted psychotherapy began gaining traction.

There has also been a rise in the number of digital mental health services, mostly due to the COVID-19 pandemic and the social isolation rules imposed by the government.

At the end of 2020, Modern Health’s mental health platform was given a $51 million raise to expand its service options and network.

Another platform, WellDoc, recently added behavioural health programming to its platform which already consists of digital health options of hypertension, diabetes, diabetes and heart failure prevention. The platform offers users assistance in enhancing their problem-solving skills, getting better sleep, decreasing anxiety, changing their attitude and growing better social skills.

It is now possible to get help while watching Netflix as the meditation and mindfulness app is being brought to the platform. Those suffering from mental health issues can now join in between their favourite shows. In early 2021, the first of three series will be aired which teaches views the basics of meditation.

Kelsey Ramsden, the president and CEO of Mind Cure, said in a statement, “As a life sciences and digital therapeutics company, providing speed to market with novel psychedelic therapies through deeper data analytics is a strength we are developing with iSTRYM.”

“Further, as we build out our database for mental wellness, both therapists and individuals will get mental wellness protocols for wellness optimization and support. iSTRYM exists to become the source that individuals turn to for science-backed, personalized mental health support at scale.”